Effect of fecal microbiota transplantation on movement disorders

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100045397

Enrollment

Unknown

Registered

2021-04-14

Start date

2021-06-01

Completion date

Unknown

Last updated

2022-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Movement disorders

Interventions

Dyskinesia patient group:Fecal microbiota transplantation

Healthy control group:Fecal microbiota transplantation

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. The patient meets the diagnostic criteria of movement disorders; 2. Voluntary acceptance of bacterial community transplantation therapy and contraindication of sterile group transplantation therapy; 3. Informed consent was given by the patient and his/her family and informed consent was filled in.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Patients with end-stage diseases; 3. Cases who are participating in or have participated in other clinical trials within 3 months; 4. Previous history of intestinal pathogen infection; 5. Oral antibiotics or proton pump inhibitors (PPI) in recent 2 weeks and immunosuppressed.

Design outcomes

Primary

Measure	Time frame
Fecal microbiota;Motor function;	—

Countries

China

Contacts

Public ContactTeng Junfang

The First Affiliated Hospital of Zhengzhou University

13838210077@163.cm+86 13738210077

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026